Sienna Biopharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Cash & Equivalents	48.53	74.47	9.09	4.96
Cash & Short-Term Investments	48.53	74.47	9.09	4.96
Cash Growth	-34.84%	719.13%	83.21%	-
Prepaid Expenses	1.71	2.7	1.32	0.62
Restricted Cash	0.18	0.18	0.11	0.04
Other Current Assets	-	-	-	0.02
Total Current Assets	50.41	77.35	10.52	5.64
Property, Plant & Equipment	0.31	0.43	0.29	0.11
Goodwill	10.99	11.47	9.7	-
Long-Term Deferred Charges	45.59	47.6	41.86	-
Other Long-Term Assets	-	-	0	-
Total Assets	107.31	136.85	62.38	5.75
Accounts Payable	2.79	2.36	1.69	0.81
Accrued Expenses	7.84	5.65	3.06	0.2
Other Current Liabilities	13.71	0.23	5.14	-
Total Current Liabilities	24.35	8.24	9.88	1.01
Long-Term Debt	30.13	-	-	-
Long-Term Deferred Tax Liabilities	10.5	10.96	9.33	-
Other Long-Term Liabilities	15.75	26.44	21.05	0.69
Total Liabilities	80.73	45.65	40.26	1.7
Common Stock	-	-	0	0
Additional Paid-In Capital	182.75	171.73	-	-
Retained Earnings	-159.37	-85.9	-35.35	-14.19
Comprehensive Income & Other	3.2	5.37	-2.05	-2.11
Total Common Equity	26.58	91.2	-37.4	-16.3
Shareholders' Equity	26.58	91.2	22.12	4.05
Total Liabilities & Equity	107.31	136.85	62.38	5.75
Total Debt	30.13	-	-	-
Net Cash (Debt)	18.4	74.47	9.09	4.96
Net Cash Growth	-75.29%	719.13%	83.21%	-
Net Cash Per Share	0.90	7.65	5.37	2.90
Filing Date Shares Outstanding	30.07	20.19	1.72	1.69
Total Common Shares Outstanding	20.87	20.19	1.72	1.69
Working Capital	26.06	69.11	0.64	4.63
Book Value Per Share	1.27	4.52	-21.75	-9.65
Tangible Book Value	15.59	79.73	-47.1	-16.3
Tangible Book Value Per Share	0.75	3.95	-27.39	-9.65
Machinery	0.54	0.51	0.35	0.12
Leasehold Improvements	0.11	0.11	0.02	-

Updated Nov 12, 2019. Source: S&P Global Market Intelligence. Standard template. Financial Sources.